Cargando…

Novel transcription-induced fusion RNAs in prostate cancer

Prostate cancer is a clinically and pathologically heterogeneous disease with a broad spectrum of molecular abnormalities in the genome and transcriptome. One key feature is the involvement of chromosomal rearrangements creating fusion genes. Recent RNA-sequencing technology has uncovered that fusio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Sen, Løvf, Marthe, Carm, Kristina Totland, Bakken, Anne Cathrine, Hoff, Andreas M., Skotheim, Rolf I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564755/ https://www.ncbi.nlm.nih.gov/pubmed/28467780 http://dx.doi.org/10.18632/oncotarget.17099

Ejemplares similares

Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer
por: Carm, Kristina Totland, et al.
Publicado: (2019)

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity
por: Kidd, Susanne G., et al.
Publicado: (2021)

In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis
por: Kidd, Susanne G., et al.
Publicado: (2022)

High Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants
por: Nome, Torfinn, et al.
Publicado: (2014)

Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer
por: Carm, Kristina T., et al.
Publicado: (2022)

Novel RNA variants in colorectal cancers
por: Hoff, Andreas M., et al.
Publicado: (2015)

ScaR—a tool for sensitive detection of known fusion transcripts: establishing prevalence of fusions in testicular germ cell tumors
por: Zhao, Sen, et al.
Publicado: (2020)

Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray
por: Løvf, Marthe, et al.
Publicado: (2013)

A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
por: Skotheim, Rolf I, et al.
Publicado: (2009)

chimeraviz: a tool for visualizing chimeric RNA
por: Lågstad, Stian, et al.
Publicado: (2017)

A Tumor-Associated Mutation of FYVE-CENT Prevents Its Interaction with Beclin 1 and Interferes with Cytokinesis
por: Sagona, Antonia P., et al.
Publicado: (2011)

A new blood based epigenetic age predictor for adolescents and young adults
por: Aanes, Håvard, et al.
Publicado: (2023)

Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations
por: Lorenz, Susanne, et al.
Publicado: (2015)

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
por: Cekaite, Lina, et al.
Publicado: (2015)

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
por: Ribeiro, Franclim R., et al.
Publicado: (2011)

Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing’s Sarcoma and Prostate Carcinoma
por: Camões, Maria J., et al.
Publicado: (2012)

Identification of the cross-strand chimeric RNAs generated by fusions of bi-directional transcripts
por: Wang, Yuting, et al.
Publicado: (2021)

Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer
por: Scaravilli, Mauro, et al.
Publicado: (2021)

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
por: Kim, Daehwan, et al.
Publicado: (2011)

Involvement of DPP9 in gene fusions in serous ovarian carcinoma
por: Smebye, Marianne Lislerud, et al.
Publicado: (2017)

The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
por: Hansen, Emma Bollmann, et al.
Publicado: (2022)

Detection of fusion gene transcripts in the blood samples of prostate cancer patients
por: Yu, Yan-Ping, et al.
Publicado: (2021)

TIN: An R Package for Transcriptome Instability Analysis
por: Johannessen, Bjarne, et al.
Publicado: (2015)

Noncoding RNAs as Novel Biomarkers in Prostate Cancer
por: Rönnau, C. G. H., et al.
Publicado: (2014)

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
por: Mesquita, Diana, et al.
Publicado: (2015)

Alu-directed transcriptional regulation of some novel miRNAs
por: Gu, Tong J, et al.
Publicado: (2009)

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
por: Berglund, Anders E., et al.
Publicado: (2018)

Novel kinase fusion transcripts found in endometrial cancer
por: Tamura, Ryo, et al.
Publicado: (2015)

Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma
por: Nyquist, Kaja B., et al.
Publicado: (2012)

Exome Sequencing of Bilateral Testicular Germ Cell Tumors Suggests Independent Development Lineages()()
por: Brabrand, Sigmund, et al.
Publicado: (2015)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells
por: Qin, Fujun, et al.
Publicado: (2015)

Do Non-Genomically Encoded Fusion Transcripts Cause Recurrent Chromosomal Translocations?
por: Kowarz, Eric, et al.
Publicado: (2012)

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
por: Celestino, Ricardo, et al.
Publicado: (2018)

Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions
por: Keck, Bastian, et al.
Publicado: (2021)

From circRNAs to fusion circRNAs in hematological malignancies
por: Babin, Loelia, et al.
Publicado: (2021)

Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome
por: Przybylski, Grzegorz K., et al.
Publicado: (2017)

Correction: Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells
por: Qin, Fujun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8qil0v65mn77pgbo9sq1agnesm